{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:46:19Z","timestamp":1751953579479},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Cancer Institute of the United States of America","award":["CA154151"],"award-info":[{"award-number":["CA154151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11434-015-0772-5","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T06:08:04Z","timestamp":1429164484000},"page":"762-772","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Inflammatory Models Drastically Alter Tumor Growth and the Immune Microenvironment in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"60","author":[{"given":"Geoffrey J.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Michelotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11434-015-0772-5_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view","volume":"7","author":"Yang","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1007\/s11434-015-0772-5_bib2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1007\/s11434-015-0772-5_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1007\/s11434-015-0772-5_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1007\/s11434-015-0772-5_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/nsr\/nwu038","article-title":"The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma","volume":"1","author":"Yang","year":"2014","journal-title":"Natl Sci Rev"},{"key":"10.1007\/s11434-015-0772-5_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20060242","article-title":"Liver fibrosis: cellular mechanisms of progression and resolution","volume":"112","author":"Henderson","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1007\/s11434-015-0772-5_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1007\/s11434-015-0772-5_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2009.12.001","article-title":"The immunology of fibrosis: innate and adaptive responses","volume":"31","author":"Wick","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1007\/s11434-015-0772-5_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1007\/s11434-015-0772-5_bib10","first-page":"65","article-title":"Accumulation of extracellular matrix in the liver induces high metastatic potential of hepatocellular carcinoma to the lung","volume":"19","author":"Sawada","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1007\/s11434-015-0772-5_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","article-title":"TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma","volume":"22","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1007\/s11434-015-0772-5_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","article-title":"Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling","volume":"155","author":"He","year":"2013","journal-title":"Cell"},{"key":"10.1007\/s11434-015-0772-5_bib13","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/labinvest.2010.139","article-title":"Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity","volume":"90","author":"Yang","year":"2010","journal-title":"Lab Invest"},{"key":"10.1007\/s11434-015-0772-5_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023943","article-title":"Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer","volume":"6","author":"Philips","year":"2011","journal-title":"PLoS One"},{"key":"10.1007\/s11434-015-0772-5_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1007\/s11434-015-0772-5_bib16","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J Immunol"},{"key":"10.1007\/s11434-015-0772-5_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cytogfr.2014.07.018","article-title":"The IL-2 cytokine family in cancer immunotherapy","volume":"25","author":"Sim","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1007\/s11434-015-0772-5_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cyto.2014.11.024","article-title":"T cell exhaustion and Interleukin 2 downregulation","volume":"71","author":"Balkhi","year":"2015","journal-title":"Cytokine"},{"key":"10.1007\/s11434-015-0772-5_bib19","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"184","author":"Su","year":"2010","journal-title":"J Immunol"},{"key":"10.1007\/s11434-015-0772-5_bib20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/gutjnl-2011-301116","article-title":"Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer","volume":"61","author":"Schneider","year":"2012","journal-title":"Gut"},{"key":"10.1007\/s11434-015-0772-5_bib21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J Hepatol"},{"key":"10.1007\/s11434-015-0772-5_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00262-010-0849-6","article-title":"Th17 cells: positive or negative role in tumor?","volume":"59","author":"Ji","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1007\/s11434-015-0772-5_bib23","first-page":"164","article-title":"Interleukin-17 and its expanding biological functions","volume":"7","author":"Xu","year":"2010","journal-title":"Nature"},{"key":"10.1007\/s11434-015-0772-5_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1007\/s11434-015-0772-5_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-40","article-title":"Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection","volume":"8","author":"Du","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1007\/s11434-015-0772-5_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-32-3","article-title":"High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma","volume":"32","author":"Liao","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1007\/s11434-015-0772-5_bib27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1007\/s11434-015-0772-5_bib28","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatology"},{"key":"10.1007\/s11434-015-0772-5_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1007\/s11434-015-0772-5_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology"},{"key":"10.1007\/s11434-015-0772-5_bib31","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-12-3381","article-title":"Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality","volume":"73","author":"Kalathil","year":"2013","journal-title":"Cancer Res"},{"key":"10.1007\/s11434-015-0772-5_bib32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2013.06.010","article-title":"Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma","volume":"59","author":"Kapanadze","year":"2013","journal-title":"J Hepatol"},{"key":"10.1007\/s11434-015-0772-5_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1007\/s11434-015-0772-5_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/2326-6066.CIR-13-0209","article-title":"The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells","volume":"2","author":"Elpek","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1007\/s11434-015-0772-5_bib35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep.26790","article-title":"Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha\/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice","volume":"59","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.1007\/s11434-015-0772-5_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1746.2008.05496.x","article-title":"Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure","volume":"24","author":"Banas","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1007\/s11434-015-0772-5_bib37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2011.11.030","article-title":"Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice","volume":"142","author":"Woo","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1007\/s11434-015-0772-5_bib38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","article-title":"N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation","volume":"71","author":"Verna","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s11434-015-0772-5_bib39","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKK\u03b2 couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"10.1007\/s11434-015-0772-5_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/bjc.1978.89","article-title":"Influence of repeated liver regeneration on hepatic carcinogenesis by diethylnitrosamine in mice","volume":"37","author":"Pound","year":"1978","journal-title":"Br J Cancer"},{"key":"10.1007\/s11434-015-0772-5_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2007-1007114","article-title":"Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease","volume":"19","author":"Fausto","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1007\/s11434-015-0772-5_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2010.11.014","article-title":"Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges","volume":"305","author":"Bouchard","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1007\/s11434-015-0772-5_bib43","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1007\/s11434-015-0772-5_bib44","first-page":"6665","article-title":"Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis","volume":"61","author":"Im","year":"2001","journal-title":"Cancer Res"},{"key":"10.1007\/s11434-015-0772-5_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-\u03baB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"key":"10.1007\/s11434-015-0772-5_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccr.2009.08.021","article-title":"A lymphotoxin-driven pathway to hepatocellular carcinoma","volume":"16","author":"Haybaeck","year":"2009","journal-title":"Cancer Cell"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927316304388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927316304388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11434-015-0772-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T13:22:28Z","timestamp":1537708948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927316304388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S2095927316304388"],"URL":"https:\/\/doi.org\/10.1007\/s11434-015-0772-5","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}